NewAmsterdam Pharma Company NV (NASDAQ:NAMS) does about 169.12K shares in volume on a normal day but saw 3847419 shares change hands in the recent trading day. The company now has a market cap of 1.55B USD. Its current market price is $17.25, marking a decrease of -8.54% compared to the previous close of $18.86. The 52 week high reached by this stock is $26.35 whilst the lowest price level in 52 weeks is $5.63.
NewAmsterdam Pharma Company NV (NAMS) has a 20-day trading average at $19.48 and the current price is -34.54% off the 52-week high compared with 206.25% distance from its 52-week low. The 50-day simple moving average of the closing price is $19.28 and its 200-day simple moving average is $17.07. If we look at the stock’s price movements over the week, volatility stands at 5.24%, which decreases to 5.17% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 30.75 to suggest the stock is neutral.
The consensus objective for the share price is $36.86, suggesting that the stock has a potential upside of 53.2% over the period.
1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
Guggenheim initiated its price target at $30.
NewAmsterdam Pharma Company NV (NAMS) stock is down -9.21% over the week and -11.72% over the past month. Its price is 54.43% year-to-date and 49.35% over the past year.
To reach the target analysts have set, the stock logically needs to grow 53.2 percent from here.
The beta has a value of 0.02. Price to book ratio is 3.76.
